AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:NEOGNeogen Stock Price, Forecast & News

$72.76
+3.46 (+4.99 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$68.54
Now: $72.76
$72.88
50-Day Range
$61.02
MA: $64.58
$69.30
52-Week Range
$48.91
Now: $72.76
$79.83
Volume257,300 shs
Average Volume232,888 shs
Market Capitalization$3.84 billion
P/E Ratio64.96
Dividend YieldN/A
Beta0.7
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.
Read More
Neogen logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$414.19 million
Cash Flow$1.63 per share
Book Value$12.24 per share

Profitability

Net Income$60.18 million

Miscellaneous

Employees1,682
Market Cap$3.84 billion
Next Earnings Date7/28/2020 (Estimated)
OptionableOptionable

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Neogen (NASDAQ:NEOG) Frequently Asked Questions

How has Neogen's stock been impacted by COVID-19 (Coronavirus)?

Neogen's stock was trading at $60.73 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEOG shares have increased by 19.8% and is now trading at $72.76. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Neogen.

When is Neogen's next earnings date?

Neogen is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Neogen.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) released its earnings results on Tuesday, March, 24th. The company reported $0.23 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.27 by $0.04. The company had revenue of $99.60 million for the quarter, compared to the consensus estimate of $102.42 million. Neogen had a net margin of 14.07% and a return on equity of 8.73%. The firm's revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.25 earnings per share. View Neogen's earnings history.

When did Neogen's stock split? How did Neogen's stock split work?

Neogen shares split on the morning of Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were distributed to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How will Neogen's stock buyback program work?

Neogen announced that its Board of Directors has initiated a stock buyback plan on Wednesday, October 10th 2018, which allows the company to buyback 3,000,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to buy shares of its stock through open market purchases. Stock buyback plans are often an indication that the company's board believes its stock is undervalued.

What price target have analysts set for NEOG?

3 brokers have issued twelve-month price targets for Neogen's shares. Their forecasts range from $78.00 to $88.00. On average, they anticipate Neogen's stock price to reach $83.00 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price. View analysts' price targets for Neogen.

Has Neogen been receiving favorable news coverage?

News stories about NEOG stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neogen earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutNeogen.

Who are some of Neogen's key competitors?

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), AT&T (T), Pfizer (PFE), Gilead Sciences (GILD), AbbVie (ABBV), JPMorgan Chase & Co. (JPM), WP Carey (WPC), Adobe (ADBE), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Who are Neogen's key executives?

Neogen's management team includes the following people:
  • Mr. James L. Herbert, Exec. Chairman (Age 79)
  • Mr. John Edward Adent, CEO & Pres (Age 51)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 57)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 54)
  • Mr. Rod Poland, Director of Corp. Communications

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

Who are Neogen's major shareholders?

Neogen's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.73%), Brown Capital Management LLC (12.63%), Wasatch Advisors Inc. (4.34%), Fred Alger Management LLC (3.65%), State Street Corp (3.33%) and Conestoga Capital Advisors LLC (3.14%). Company insiders that own Neogen stock include Jack C Parnell, James L Herbert, James P Tobin, Jason Warren Lilly, John Edward Adent, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View institutional ownership trends for Neogen.

Which institutional investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Wasatch Advisors Inc., Nuveen Asset Management LLC, BlackRock Inc., Morgan Stanley, Morgan Stanley, Brown Capital Management LLC, and Franklin Resources Inc.. Company insiders that have sold Neogen company stock in the last year include Jack C Parnell, James L Herbert, Jason Warren Lilly, John Edward Adent, Steven J Quinlan, Terri A Morrical, Thomas H Reed, and William T Boehm. View insider buying and selling activity for Neogen.

Which institutional investors are buying Neogen stock?

NEOG stock was bought by a variety of institutional investors in the last quarter, including Mitsubishi UFJ Trust & Banking Corp, State Street Corp, Conestoga Capital Advisors LLC, JPMorgan Chase & Co., Geode Capital Management LLC, Advantage Alpha Capital Partners LP, Deutsche Bank AG, and Aviva PLC. Company insiders that have bought Neogen stock in the last two years include James P Tobin, and John Edward Adent. View insider buying and selling activity for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $72.76.

How big of a company is Neogen?

Neogen has a market capitalization of $3.84 billion and generates $414.19 million in revenue each year. The company earns $60.18 million in net income (profit) each year or $1.15 on an earnings per share basis. Neogen employs 1,682 workers across the globe.

What is Neogen's official website?

The official website for Neogen is www.neogen.com.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.